Signals for malaria infection

coupled receptor signals may control malarial infection

Written byTudor Toma
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Plasmodium falciparum—the species that causes the most virulent human form of malaria—infects both hepatocytes and mature red blood cells (erythrocytes). The erythrocytic stages are responsible for the symptoms associated with the disease (e.g., fever, headache, and back pain), but the mechanisms involved in malarial infection have been poorly understood. In the September 19 Science, Travis Harrison and colleagues at the Feinberg School of Medicine show that signaling via the erythrocyte β2-adrenergic receptor and Gαs regulates erythrocytic stages of malarial infection across Plasmodium species (Science, 301:1734-1736, September 19, 2003).

Harrison et al. examined cocultures of parasites and erythrocytic peptides and observed that agonists that stimulate cyclic adenosine 3',5'-monophosphate production caused an increase in malarial infection that could be blocked by specific receptor antagonists. In addition, the authors showed that peptides designed to inhibit Gαs protein function reduced parasitemia in P. falciparum cultures in vitro, and β-antagonists reduced parasitemia of P. berghei ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies